|
|
|
|
Search: 
Latin American Herald Tribune
Venezuela Overview
Venezuelan Embassies & Consulates Around The World
Sites/Blogs about Venezuela
Venezuelan Newspapers
Facts about Venezuela
Venezuela Tourism
Embassies in Caracas

Colombia Overview
Colombian Embassies & Consulates Around the World
Government Links
Embassies in Bogota
Media
Sites/Blogs about Colombia
Educational Institutions

Stocks

Commodities
Crude Oil
US Gasoline Prices
Natural Gas
Gold
Silver
Copper

Euro
UK Pound
Australia Dollar
Canada Dollar
Brazil Real
Mexico Peso
India Rupee

Antigua & Barbuda
Aruba
Barbados
Cayman Islands
Cuba
Curacao
Dominica

Grenada
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines

Belize
Costa Rica
El Salvador
Honduras
Nicaragua
Panama

Bahamas
Bermuda
Mexico

Argentina
Brazil
Chile
Guyana
Paraguay
Peru
Uruguay

What's New at LAHT?
Follow Us On Facebook
Follow Us On Twitter
Most Viewed on the Web
Popular on Twitter
Receive Our Daily Headlines


  HOME | Brazil (Click here for more)

Brazil Announces Positive Results in ‘Early’ Treatment for COVID-19



BRASILIA – The Brazilian government announced on Monday that it had obtained “positive results” in an “early” treatment against COVID-19, through the application of the antiparasitic nitazoxanide in patients who have the infectious disease in its initial phase.

The announcement was made in a ceremony led by President Jair Bolsonaro, who recalled that he had defended the treatment of COVID-19 with hydroxychloroquine, which is still not endorsed by the world’s scientific community, and asked people not to distrust the possibilities that nitazoxanide can offer.

The results were presented by doctor Patricia Rocco, coordinator of the study and specialist in lung diseases with more than 30 years of experience, who said at the ceremony that the treatment showed that nitazoxanide was “effective” in reducing the viral load of patients who had already contracted COVID-19.

She explained that between June and August, 1,575 volunteers who had coronavirus in an initial phase were treated with this drug and in 95 percent of cases there was a reduction in viral load “without damage to lung cells” or other collateral problems.

Rocco said the patients received 500 milligrams of nitazoxanide three times a day for five days, but declined to provide further details on the treatment because the study results have been referred to an international “major scientific journal” for examination.

The Minister of Science and Technology, Marcos Pontes, said that “science is the only weapon we have to fight the virus,” and appreciated the effort made by the promoters of the study.

“We have a scientifically proven medication that can reduce the viral load. This means, in practice, that it reduces the contagion,” said Pontes.

“It is a low-cost drug, it works to reduce viral load, but it is not preventive, so it cannot be used before” a person contracts COVID-19, Pontes said.

 

Enter your email address to subscribe to free headlines (and great cartoons so every email has a happy ending!) from the Latin American Herald Tribune:

 

Copyright Latin American Herald Tribune - 2005-2020 © All rights reserved